Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

The LEPR rs1137101 Variant, the Cagrilintide Pathway, and Weight Management: What Your Genotype May Mean

Cagrilintide is a synthetic peptide that mimics amylin, a hormone released with insulin after meals. Amylin helps the body manage appetite, slows stomach emptying, and supports healthy post-meal blood sugar control, which can increase fullness and reduce food intake. Researchers study these pathways because they are part of the brain, gut, and pancreas network that helps balance energy and body weight. The LEPR gene is also important in this system because it makes the leptin receptor, which helps the brain sense energy stores and regulate hunger and energy use. Amylin and leptin signals work in related brain pathways, so changes in LEPR may influence how strongly these messages are received. Together, these systems show how genetics and hormones can shape metabolism, appetite, and weight management in different ways for different people.

Genetic variation in the LEPR gene may influence how efficiently the biological processes connected to Cagrilintide and Weight Management function. The rs1137101 variant is analyzed in the PlexusDx Precision Peptide Genetic Test as part of the Weight Management pathway. Depending on your genotype, this variant may have a modest to meaningful influence on adipokine signaling, insulin sensitivity, and metabolic regulation. Understanding your result gives you a personalized starting point for targeted lifestyle, dietary, and supplement strategies grounded in your unique biology.

Practical Foundations for Everyone

Regardless of your LEPR rs1137101 genotype, the following lifestyle inputs consistently support body composition, metabolic balance, and fat metabolism efficiency. Carriers of the effect allele often notice a stronger return on these habits when applied consistently — which makes regularity more valuable than intensity.

  • Consistent nutrition: A whole-food dietary pattern rich in vegetables, quality protein, healthy fats, and fiber provides the micronutrient foundation that supports weight management-related pathways at a cellular level.
  • Regular movement: Physical activity — particularly a combination of aerobic exercise and resistance training — supports the metabolic signaling and growth factor pathways that interact with weight management and biological resilience.
  • Quality sleep: Restorative sleep is essential for cellular repair, hormone regulation, and the metabolic processes that underpin weight management. Consistent sleep timing amplifies the benefits of other lifestyle habits.
  • Stress management: Chronic stress elevates cortisol and inflammatory markers that can blunt the efficiency of pathways related to weight management. A daily stress-reduction practice — even five to ten minutes of slow breathing or mindfulness — helps maintain biological balance.

Diet Recommendations for LEPR rs1137101 and the Cagrilintide Pathway

A targeted nutritional approach for the LEPR rs1137101 variant focuses on supplying the micronutrients and macronutrient balance that support adipokine signaling, insulin sensitivity, and metabolic regulation and reduce the metabolic burden on pathways connected to Cagrilintide. Priority nutrients vary by pathway but consistently center on anti-inflammatory whole foods, adequate protein for cellular and tissue support, and micronutrient density from colorful produce and quality fats.

The GLP-1 Support is designed to support this pathway. A nutrient-dense plan supporting GLP-1 medications with protein, healthy fats, and fiber to enhance results and minimize side effects....

Build meals around quality protein sources (fish, poultry, legumes, eggs), fiber-rich carbohydrates (vegetables, whole grains, legumes), and healthy fats (olive oil, avocado, nuts, seeds). Minimize ultra-processed foods, excessive added sugars, and alcohol — all of which increase oxidative and inflammatory burden on pathways that interact with weight management and Cagrilintide-related signaling.

Supplement Considerations for LEPR rs1137101 Support

Supplements cannot modify your LEPR rs1137101 genotype, but targeted supplementation can address nutritional gaps and support the biological pathways connected to Cagrilintide and weight management. A foundations-first approach — prioritizing the basics before adding specialty products — produces the most consistent outcomes. Always discuss supplementation with your healthcare provider before starting, especially if you take medications or manage ongoing health conditions.

The PlexusDx Weight Loss Support is a personalized daily pack designed to support this pathway. PlexusDx Weight Loss Support Personalized Daily Pack combines berberine, green tea extract, and Forslean to help support healthy metabolism and promote effective weight management. Convenient pre-portioned packs make it easy to stay consistent while supporting energy, fat metabol...

Key nutrients commonly relevant to the Weight Management pathway include those that support adipokine signaling, insulin sensitivity, and metabolic regulation. Assess dietary gaps first; targeted supplementation is most valuable when it addresses a specific nutritional shortfall confirmed by food tracking or lab results rather than used as a substitute for consistent lifestyle habits.

Lifestyle Recommendations for Weight Management and Cagrilintide Pathway Support

Consistent lifestyle habits are the most durable and evidence-supported way to reinforce the biological pathways associated with Cagrilintide and weight management. For carriers of the LEPR rs1137101 effect allele, these habits tend to produce a more noticeable return because they directly influence the signaling environments where the variant has its greatest impact.

A practical weekly target is 150 minutes or more of moderate aerobic activity combined with two to three resistance training sessions. Sleep consistency — a fixed wake time, morning outdoor light, and a 60 to 90 minute wind-down before bed — supports cellular recovery and the hormonal balance that underpins weight management. Stress management practices such as slow breathing, mindfulness, or low-stimulation outdoor time help maintain the biological stability that Cagrilintide-related pathways depend on for efficient function. Avoiding chronic sleep debt, late-day caffeine, and excessive alcohol further removes common suppressors of weight management-related signaling.

Genetic Interpretations for rs1137101 (LEPR)

2 Effect Alleles: GG (+/+)

You have the GG genotype for rs1137101 which means you carry two copies of the effect allele. This variation is associated with altered leptin receptor signaling and, in many studies, has been linked to a greater tendency toward reduced leptin sensitivity, higher obesity risk, and differences in appetite regulation and long-term energy balance. In the context of the Cagrilintide pathway, this is relevant because Cagrilintide is an amylin analog that promotes satiety and slows gastric emptying, while LEPR helps regulate the parallel leptin-signaling system that tells the brain how much stored energy is available. Amylin and leptin pathways interact in appetite-regulating circuits, so if leptin signaling is less efficient, the overall satiety environment may be somewhat less favorable even when amylin-related signals are present. Research on rs1137101, often described as the Q223R variant, has shown recurring associations with obesity and leptin-related metabolic traits, although effect size varies by population. For individuals with the GG genotype, practical support may include emphasizing protein-rich meals, high-fiber carbohydrates, consistent meal timing, regular exercise, restorative sleep, and minimizing ultra-processed foods that can worsen appetite dysregulation. Overall, this genotype does not determine weight outcome on its own, but it may indicate that satiety signaling and appetite control are especially important within the broader metabolic environment relevant to Cagrilintide.

1 Effect Allele: GA (+/-)

You have the GA genotype for rs1137101, which means you carry one copy of the effect allele and one copy of the non-effect allele. This intermediate genotype may be associated with a moderate change in leptin receptor responsiveness, often representing a middle-ground pattern between the two homozygous genotypes. In connection with the Cagrilintide pathway, this suggests that leptin-related regulation of appetite and energy expenditure is likely to remain broadly functional, but may show some individual variation in efficiency depending on overall metabolic health, diet quality, sleep, and body composition. Because amylin signaling works alongside leptin-sensitive appetite circuits in the brain, even modest changes in LEPR function may influence how strongly satiety signals are integrated over time. The literature around rs1137101 is not fully uniform across all ethnic groups and study designs, but recent meta-analysis supports interpreting it as a moderate metabolic risk modifier rather than a strong deterministic factor. For this genotype, the most useful approach is usually to optimize the surrounding metabolic environment through balanced calorie intake, adequate protein, high-fiber foods, regular physical activity, and strong sleep and stress-management habits. Overall, this genotype is best viewed as a moderate-response marker within the broader leptin-amylin appetite network relevant to Cagrilintide.

0 Effect Alleles: AA (-/-)

You have the AA genotype for rs1137101 which means you carry two copies of the non-effect allele. This genotype is generally associated with typical leptin receptor signaling and a more standard pattern of appetite and energy-balance regulation. In the context of the Cagrilintide pathway, this suggests that the LEPR portion of body-weight regulation is more likely to function within the expected range, helping support more typical communication between adipose tissue and the brain regarding hunger and energy stores. Since Cagrilintide is designed to mimic amylin, which promotes satiety and delays gastric emptying, this genotype may indicate that upstream leptin-signaling tendencies are less likely to be a major limiting factor in the broader satiety network. That said, body composition and weight regulation still depend heavily on total calorie intake, diet quality, physical activity, sleep, inflammation, and insulin sensitivity, so this genotype should not be interpreted as guaranteeing easy weight control. The main recommendations for this genotype are therefore foundational: a nutrient-dense diet, adequate protein and fiber intake, regular exercise, good sleep, and consistent habits that support healthy body composition and metabolic health. Overall, this genotype is generally consistent with a more typical LEPR-mediated contribution to the broader neuroendocrine pathways of satiety and energy balance relevant to Cagrilintide.

Inconclusive — No Result

Your genetic data for rs1137101, a LEPR gene variant, was not successfully called by the laboratory. This means the test did not detect a reliable result for this position, which can occur for technical reasons such as low signal intensity, DNA quality issues, or limitations of the genotyping array. Without a result, we cannot determine whether you carry the typical or effect variant for this gene. If this information is important for your health decisions, you may wish to consider retesting or confirming this variant through a targeted genetic test or sequencing method.

When to Talk to Your Healthcare Provider

If you have concerns related to weight management, the Cagrilintide pathway, or how your LEPR rs1137101 results fit into your broader health picture, consult your healthcare provider. They can interpret your genetic results alongside your symptoms, health history, and lab values to guide appropriate testing, dietary adjustments, and supplementation where relevant.

PlexusDx provides genetic insights to help you understand how your genes may influence nutrient needs and biological pathways. This information is provided for educational and wellness purposes only and does not diagnose, treat, or recommend any specific medication, peptide, or therapy, some of which may be prescription-only, investigational, or intended for research use only. Always consult with a qualified healthcare provider before making changes to your supplement regimen, diet, or health plan based on genetic information.

Frequently Asked Questions About LEPR rs1137101 and Cagrilintide

What does the LEPR rs1137101 variant mean for my weight management?

The rs1137101 variant in the LEPR gene may influence how efficiently biological processes connected to Cagrilintide and Weight Management function in your body. Depending on your genotype, this can have a modest to meaningful effect on adipokine signaling, insulin sensitivity, and metabolic regulation. Understanding your result gives you a personalized starting point for a targeted lifestyle and nutrition strategy grounded in your unique genetic biology.

How does the Cagrilintide pathway relate to LEPR and weight management?

Cagrilintide is a peptide being studied for its potential role in supporting body composition, metabolic balance, and fat metabolism efficiency. Researchers are interested in how Cagrilintide-associated pathways may interact with genes like LEPR, which contribute to the signaling environments that influence weight management function. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150 genetic insights — including LEPR rs1137101 — to provide a comprehensive view of how your genetics may influence these interconnected systems.

Can lifestyle changes support LEPR function regardless of my genotype?

Yes. Consistent lifestyle habits — regular exercise, quality sleep, anti-inflammatory nutrition, and stress management — support weight management-related biological pathways across all genotypes. For carriers of the effect allele at rs1137101, these habits tend to produce a stronger measurable return because they directly reinforce the signaling environments where this variant has its greatest influence. Consistency and habit stacking — combining exercise, sleep, and nutrition improvements together — tends to produce better outcomes than any single change in isolation.

What tests can help me learn more about my weight management and the Cagrilintide pathway?

The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150 genetic insights — including LEPR rs1137101 — to deliver a comprehensive picture of how your genetics may influence peptide-related health pathways. The Peptide Pathways Report translates your results into personalized, actionable guidance. Your healthcare provider can also recommend targeted blood tests based on your specific pathway results and health history to complement your genetic insights with current biomarker data.

If this genetic variant is present in your PlexusDx results, the following tests and reports are commonly used to explore it further:

🧬 Genetic Tests:

📄 Genetic Report:

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.